Showing results (411-420 of 831) with videos related to

Sort By:
Pageof 84
BMC Public Health|May 4, 2006
"Sleepiness" is serious in adolescence: two surveys of 3235 Canadian studentsEdward S Gibson, A C Peter Powles, Lehana Thabane, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2013
Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndromeApostolia M Tsimberidou, William G Wierda, Sijin Wen, et al.
Leukemia & Lymphoma|April 6, 2012
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemiaJohn C Byrd, Thomas J Kipps, Ian W Flinn, et al.
Blood|November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignanciesJorge Cortes, Maher Albitar, Deborah Thomas, et al.
Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Cancer|June 16, 2004
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemiaApostolia M Tsimberidou, Michael J Keating, Francis J Giles, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 22, 2008
Aurora-A kinase nuclear expression in chronic lymphocytic leukemiaKedar V Inamdar, Susan O'Brien, Subrata Sen, et al.
Cancer|April 2, 2011
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcomeIssa F Khouri, Roland Bassett, Nancy Poindexter, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemiaMeir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Pageof 84